From: α5-nAChR/NETO2 contributed to chronic stress-promoted lung adenocarcinoma progression
α5-nAChR | NETO2 | |||||||
---|---|---|---|---|---|---|---|---|
Clinical pathology | Case | Negative | Positive | P | Negative | Positive | P | |
(n = 55) | (n = 20) | (n = 35) | (n = 18) | (n = 37) | ||||
Sex | ||||||||
Male | 30 | 11 | 19 | 0.959 | 10 | 20 | 0.916 | |
Female | 25 | 9 | 16 | 8 | 17 | |||
Age(years) | ||||||||
≤ 60 | 19 | 10 | 9 | 0.068 | 9 | 10 | 0.093 | |
>60 | 36 | 10 | 26 | 9 | 27 | |||
Smoking history | ||||||||
No | 30 | 15 | 15 | 0.021 | 14 | 16 | 0.016 | |
Yes | 25 | 5 | 20 | 4 | 21 |